Please wait a minute...
Journal of ZheJiang University(Medical Science)  2013, Vol. 42 Issue (6): 693-699    DOI: 10.3785/j.issn.1008-9292.2013.06.018
    
Progress on neuroprotective effects of erythropoietin
LIU Xin, WU Haiqin
Department of Neurology,The Second Affiliated Hospital,Medical College of Xi′an Jiaotong University,Xi′an 710004,China
Download: HTML (   PDF(1108KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

The function of erythropoietin (EPO) is recognized as a stimulator for proliferation of red blood cell (RBC),however,recent studies have showed that EPO and EPO-R are widely distributed in nervous system,which indicates that it may also have important functions in neurosystem.Studies proved its neuroprotective effects,especially in ischemic-hypoxic nerve tissues.These effects are mainly activated through several signal transduction pathway downstream and multiple mechanisms are involved.As a neuroprotective factor,EPO has been investigated in the clinical studies,which may lead to the clinical application in the future.



Key wordsErythropoietin/physiology      Central nervous system/physiology      Signal transduction      Erythropoietin(EPO)      Neuroprotective      Mechanism     
Received: 09 October 2012      Published: 25 November 2013
Fund:  

刘欣(1988-),女,硕士研究生,从事神经系统衰老研究.

Cite this article:

LIU Xin, WU Haiqin. Progress on neuroprotective effects of erythropoietin. Journal of ZheJiang University(Medical Science), 2013, 42(6): 693-699.

URL:

https://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2013.06.018     OR     https://www.zjujournals.com/med/Y2013/V42/I6/693


促红细胞生成素的神经保护作用

促红细胞生成素(erthropoietin,EPO)主要以调节红细胞生成而被人们广泛认识,而最近研究发现EPO及其受体在神经系统中广泛分布,提示其可能对神经系统有重要作用。许多研究证明,EPO对神经系统疾病有重要的保护作用,这种作用在低氧缺血的条件下表现特别明显。EPO主要通过激活一系列信号转导通路及多种可能的机制发挥神经保护作用。EPO作为一种神经保护剂已经应用于临床研究,但最终应用于临床治疗还需要进行大量的研究。


关键词: 红细胞生成素/生理学,  中枢神经系统/生理学,  信号传导,  促红细胞生成素,  神经保护,  作用机制 
[1] XUAN Zixue,ZHANG Yiwen,PAN Zongfu,ZHENG Xiaowei,HUANG Ping. Natural medicinal ingredients induce tumor ferroptosis and related mechanisms[J]. Journal of ZheJiang University(Medical Science), 2021, 50(5): 601-606.
[2] HU Jingyi,WANG Qingqing,LIU Yang. Research progress on proteasome subunits in regulating occurrence and development of hepatocellular carcinoma[J]. Journal of ZheJiang University(Medical Science), 2021, 50(3): 396-402.
[3] ZHU Feng,XIANG Yingchun,ZENG Linghui. Progress on mitochondrial silence information regulator family in epilepsy[J]. Journal of ZheJiang University(Medical Science), 2021, 50(3): 403-408.
[4] WANG Yanan,YAN Xiaoming,ZHANG Qingyu,SONG Aihua,HAN Fei. Study on the mechanism of Flos Puerariae and Semen Hoveniae in treatment of alcoholic liver injury based on network pharmacology and molecular docking[J]. Journal of ZheJiang University(Medical Science), 2020, 49(6): 714-724.
[5] HUANG Yaoping,YANG Feng,ZHOU Tianhua,XIE Shanshan. Emerging roles of Hippo signaling pathway in gastrointestinal cancers and its molecular mechanisms[J]. Journal of ZheJiang University(Medical Science), 2020, 49(1): 35-43.
[6] WANG Yifeng, WANG Zhiping. Research progress on intrinsic signaling pathways in axon regeneration[J]. Journal of ZheJiang University(Medical Science), 2020, 49(1): 82-89.
[7] LIU Jingwen,YANG Xinglian,SHEN Kaili,ZENG Linghui,SUN Yan. Chloroxoquinoline inhibits invasion in breast cancer via down-regulating Rho/Rho kinase signaling pathway[J]. Journal of ZheJiang University(Medical Science), 2019, 48(6): 631-637.
[8] WANG Qingmei, XU Qianzi, WEI Anyi, CHEN Shishuo, ZHANG Chong, ZENG Linghui. High dose vitamin C inhibits proliferation of breast cancer cells through reducing glycolysis and protein synthesis[J]. Journal of ZheJiang University(Medical Science), 2019, 48(3): 296-302.
[9] ZHU Ziling, TAN Jing, DENG Hong. Nucleus translocation of membrane/cytoplasm proteins in tumor cells[J]. Journal of ZheJiang University(Medical Science), 2019, 48(3): 318-325.
[10] SHAO Jiale,LI Zhizhong,ZHOU Jian,LI Kai,QIN Rong,CHEN Keming. Effect of low-frequency pulsed electromagnetic fields on activity of rat calvarial osteoblasts through IGF-1R/NO signaling pathway[J]. Journal of ZheJiang University(Medical Science), 2019, 48(2): 158-164.
[11] LIANG Gang, NIU Yumiao, LI Yihan, Wei Anyi, DONG Jingyin, ZENG Linghui. Rapamycin treatment starting at 24 h after cerebral ischemia/reperfusion exhibits protective effect on brain injury in rats[J]. Journal of ZheJiang University(Medical Science), 2018, 47(5): 443-449.
[12] ZHU Feng,FAN Miao,XU Ziwei,CAI Yiting,CHEN Yizhen,YU Shuang,ZENG Linghui. Neuroprotective effect of rapamycin against Parkinson's disease in mice[J]. Journal of ZheJiang University(Medical Science), 2018, 47(5): 465-472.
[13] QIAN Bo,ZHANG Yanling,MO Xuming. Research progress on transcription factors and signal pathways involved in congenital esophageal atresia[J]. Journal of ZheJiang University(Medical Science), 2018, 47(3): 239-243.
[14] PAN Zongfu,FANG Qilu,ZHANG Yiwen,LI Li,HUANG Ping. Identification of key pathways and drug repurposing for anaplastic thyroid carcinoma by integrated bioinformatics analysis[J]. Journal of ZheJiang University(Medical Science), 2018, 47(2): 187-193.
[15] LIU Tingting,WANG Lingxiao,YANG Xiaohui,YAO Zhiqing,CAI Huizhen. TLR/NF-κB independent signaling pathway in TNF-α suppression of diabetic MyD88-knockout mice after Lycium barbarum polysaccharides administration[J]. Journal of ZheJiang University(Medical Science), 2018, 47(1): 35-40.